Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study

PURPOSE: Treatment of rheumatic diseases with tumor necrosis factor inhibitors leads to improved clinical outcomes. Therapeutic drug monitoring (TDM) may assist in guiding clinical decisions. This study investigates the impact of TDM on clinical outcome, decision-making and biologics cost expenditur...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Lise, Szecsi, Pal Bela, Johansen, Per Birger, Bjerrum, Poul Jannik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643816/
https://www.ncbi.nlm.nih.gov/pubmed/33162753
http://dx.doi.org/10.2147/BTT.S262511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643816/
https://www.ncbi.nlm.nih.gov/pubmed/33162753
http://dx.doi.org/10.2147/BTT.S262511

Ejemplares similares